Top Stories

Will the third dose of the Kovid-19 vaccine help fight new variants? Britain’s big step to find out

Emerging corona virus variants are creating new threats amid ongoing vaccination campaigns around the world. New strains of some viruses are known to be more contagious and resistant to immunity from the approved vaccine. For instance, the Oxford-AstraZeneca covid-19 vaccine has been found to be less effective in testing against the South African variant B.1.351 of the corona virus.

Variants of corona virus increase the concern of scientists

Based on early test results, Johnson & Johnson and Novavax have also stated that South African strains and Brazilian variants may partially ignore the protection available from their vaccines. Such vaccine resistance has forced scientists to rethink the vaccine strategy, and companies are trying to develop new variant specific vaccines.

Will the third dose of the Kovid-19 vaccine help?

The option of a booster dose is also being thought to protect people from emerging variants. The British Government is giving financial assistance on a research. Its purpose is to assess the effect of the third dose of the vaccine to improve the vaccine response against current and future Kovid-19 variants.

It is believed that this is the first such research in the world. According to IANS, it was revealed from the budget on Wednesday. The funding is part of the 28 million pounds ($ 39.07 million) investment that the British government is making. Through this, the capacity of the country is to be increased for vaccine testing, human testing and improvement in qualification. The government will spend £ 22 million on research to examine the impact of the mismatch of various Kovid-19 vaccines.

In addition, the government has promised an additional 1.65 billion pounds of cash flow to ensure a successful Kovid-19 vaccination campaign in England. The vaccination campaign against Kovid-19 started in Britain on 8 December 2020 on a large scale. To protect people, a jointly developed vaccine from American pharmaceutical company Pfizer and German pharmaceutical company BioNotech was incorporated. Britain launched the affordable and easily transportable AstraZeneca-Oxford Kovid-19 vaccine on 4 January 2021. By the end of February, more than 20 million people have received the first dose of the vaccine.

Counterfeit Kovid-19 vaccine seized in China and South Africa; Interpol busted

Weight Loss: Is morning time good for weight loss exercise or not? Know the opinion of experts


Leave a Reply

Your email address will not be published. Required fields are marked *